AstraZeneca's Symbicort Inhaler Triggers Patent Suit
According to the suit, AstraZeneca and its French, Swedish and U.S. units infringed U.S. Patent Number 5,718,355 when they manufactured and sold the inhaler. The patent is entitled "Indicator device responsive to axial force for use with inhaler."
"Upon information and belief, and without authority, consent, right or license, and in...
To view the full article, register now.